Sanofi-Aventis Receives European Approval For Acomplia

Drug Industry Daily
KEYWORDS Drug Approvals / EU

The European Commission (EC) has granted marketing authorization for sanofi-aventis’ Acomplia in all 25 European member states, making it the first of a new type of drugs to be approved to treat obesity, the company said June 21.

To View This Article:


Subscribe To Drug Industry Daily